DOP2002000508A - Composición farmaceutica - Google Patents

Composición farmaceutica

Info

Publication number
DOP2002000508A
DOP2002000508A DO2002000508A DO2002000508A DOP2002000508A DO P2002000508 A DOP2002000508 A DO P2002000508A DO 2002000508 A DO2002000508 A DO 2002000508A DO 2002000508 A DO2002000508 A DO 2002000508A DO P2002000508 A DOP2002000508 A DO P2002000508A
Authority
DO
Dominican Republic
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DO2002000508A
Other languages
English (en)
Inventor
Mike Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to DO2002000508A priority Critical patent/DOP2002000508A/es
Publication of DOP2002000508A publication Critical patent/DOP2002000508A/es

Links

DO2002000508A 2002-11-12 2002-11-12 Composición farmaceutica DOP2002000508A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2002000508A DOP2002000508A (es) 2002-11-12 2002-11-12 Composición farmaceutica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2002000508A DOP2002000508A (es) 2002-11-12 2002-11-12 Composición farmaceutica

Publications (1)

Publication Number Publication Date
DOP2002000508A true DOP2002000508A (es) 2003-06-15

Family

ID=44261109

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2002000508A DOP2002000508A (es) 2002-11-12 2002-11-12 Composición farmaceutica

Country Status (1)

Country Link
DO (1) DOP2002000508A (es)

Similar Documents

Publication Publication Date Title
PT1501534E (pt) Formulacoes farmaceuticas
FI20011478A0 (fi) Farmaseuttinen koostumus
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
NO20050132D0 (no) Vaksinesammensetning
DK3384931T3 (da) Superfin formoterolformulering
ATE380544T1 (de) Umhüllte feste darreichungsform
DE10393374D2 (de) Zusammensetzung
FR2862654B1 (fr) Composition amylacee filmogene
DE602004017700D1 (de) Transmukosen verabreichung
NO20052952D0 (no) Farmasoytisk sammensetning som innbefatter mikropartikler
DK1587478T3 (da) Farmaceutisk sammensætning
SE0500163L (sv) Sammansättning
DK1425019T3 (da) Farmaceutisk sammensætning omfattende et androgen
EE200300589A (et) Ravimkoostised
DK1561472T3 (da) Faststofsammensætning
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
PT1558263E (pt) Composicao farmaceutica de libertacao prolongada
FI20022128A0 (fi) Farmaseuttinen koostumus
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DE60326900D1 (de) Duftstoff-Zusammensetzung
DE10291905D2 (de) Pharmazeutische Zusammensetzung
IS7581A (is) Lyfjasamsetning
NO20034952D0 (no) Farmasöytiske forbindelser
NO20044140D0 (no) New Composition
NO20044164L (no) Farmasoytiske sammensetninger